Publications by authors named "Annette Hubsch"

Claim this Profile
A
An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon-like peptide-1 and glucagon receptor in healthy subjects.
James Goodman, Victoria E Parker, Carmel M McEniery, Giovanni Di Stefano, Annette Hubsch

Br J Clin Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular responses to experimental weight gain in humans: a feasibility study.
Domonkos Cseh, Jessica E Middlemiss, Kaisa M Mäki-Petäjä, Annette Hubsch, Ian B Wilkinson

J Hypertens· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose nterleukin 2 for the reduction of ascular inflammatin in acute corona syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.
Rouchelle Sriranjan, Tian Xiao Zhao, Jason Tarkin, Annette Hubsch, Joanna Helmy

BMJ Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.
Tian X Zhao, Rouchelle S Sriranjan, Zewen Kelvin Tuong, Yuning Lu, Andrew P Sage, Annette Hubsch

NEJM Evid· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial.
Kaisa M Mäki-Petäjä, Adam McGeoch, Lucy L Yang, Annette Hubsch, Carmel M McEniery

Hypertension· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study.
Paul J Cacciottolo, Michalis S Kostapanos, Elena Hernan Sancho, Holly Pavey, Fotini Kaloyirou, Annette Hubsch

BMJ Open· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Carmel M McEniery, Marie Fisk, Karen Miles, Fotini Kaloyirou, Annette Hubsch

Trials· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Carmel M McEniery, Marie Fisk, Karen Miles, Fotini Kaloyirou, Annette Hubsch

Trials· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers - a mechanistic physiological study (INTENSITY-LOW): protocol and study rationale.
Michael S Kostapanos, Paul J Cacciottolo, Annette Hubsch, Holly Pavey, James Hurlock

J Drug Assess· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 Is a Coronary Artery Vasodilator in Humans.
Sophie J Clarke, Joel P Giblett, Lucy L Yang, Annette Hubsch, Tian Zhao

J Am Heart Assoc· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial.
Tian Xiao Zhao, Michalis Kostapanos, Charmaine Griffiths, Emma L Arbon, Annette Hubsch

BMJ Open· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial.
Parag R Gajendragadkar, Annette Hubsch, Kaisa M Mäki-Petäjä, Martin Serg, Ian B Wilkinson

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure.
Giacomo Pucci, Joseph Cheriyan, Annette Hubsch, Stacey S Hickson, Parag R Gajendragadkar

J Hypertens· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis